EdgarLookup

ALNYLAM PHARMACEUTICALS, INC. — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 144 15-12B 25 3 3/A 4 4/A 424B4 424B5 5 8-A12B 8-A12G 8-A12G/A 8-K ARS CORRESP CT ORDER DEF 14A DEFA14A EFFECT FWP PRE 14A PRER14A REGDEX REGDEX/A S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SCHEDULE 13G/A 0000102909-26-000562 Mar 26, 2026
4 PRIMARY DOCUMENT 0001735276-26-000063 Mar 6, 2026 Mar 4, 2026
4 PRIMARY DOCUMENT 0001735276-26-000062 Mar 6, 2026 Mar 4, 2026
4 PRIMARY DOCUMENT 0001735276-26-000061 Mar 6, 2026 Mar 4, 2026
4 PRIMARY DOCUMENT 0001735276-26-000060 Mar 6, 2026 Mar 4, 2026
4 PRIMARY DOCUMENT 0001735276-26-000059 Mar 6, 2026 Mar 4, 2026
144 0001969223-26-000296 Mar 5, 2026
144 0001969223-26-000295 Mar 5, 2026
4 PRIMARY DOCUMENT 0001735276-26-000053 Mar 4, 2026 Mar 2, 2026
4 PRIMARY DOCUMENT 0001735276-26-000052 Mar 4, 2026 Mar 2, 2026
4 PRIMARY DOCUMENT 0001735276-26-000051 Mar 4, 2026 Mar 2, 2026
4 PRIMARY DOCUMENT 0001735276-26-000050 Mar 4, 2026 Mar 2, 2026
4 PRIMARY DOCUMENT 0001735276-26-000049 Mar 4, 2026 Mar 2, 2026
4 PRIMARY DOCUMENT 0001735276-26-000048 Mar 4, 2026 Mar 2, 2026
8-K 8-K 0001628280-26-014728 Mar 4, 2026 Mar 2, 2026
144 0001969223-26-000276 Mar 3, 2026
144 0001969223-26-000273 Mar 3, 2026
4 PRIMARY DOCUMENT 0001735276-26-000041 Mar 2, 2026 Feb 27, 2026
4 PRIMARY DOCUMENT 0001735276-26-000040 Mar 2, 2026 Feb 27, 2026
4 PRIMARY DOCUMENT 0001735276-26-000039 Mar 2, 2026 Feb 27, 2026
4 PRIMARY DOCUMENT 0001735276-26-000038 Mar 2, 2026 Feb 27, 2026
144 0001969223-26-000253 Feb 27, 2026
4 PRIMARY DOCUMENT 0001735276-26-000032 Feb 25, 2026 Feb 23, 2026
4 PRIMARY DOCUMENT 0001735276-26-000029 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001735276-26-000028 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001735276-26-000027 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001735276-26-000026 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001735276-26-000025 Feb 17, 2026 Feb 12, 2026
144 0001969223-26-000186 Feb 17, 2026
S-8 S-8 0001628280-26-007687 Feb 12, 2026
10-K 10-K 0001628280-26-007497 Feb 12, 2026 Dec 31, 2025
8-K 8-K 0001628280-26-007491 Feb 12, 2026
4 PRIMARY DOCUMENT 0001735276-26-000015 Jan 14, 2026 Jan 11, 2026
4 PRIMARY DOCUMENT 0001735276-26-000014 Jan 14, 2026 Jan 11, 2026
4 PRIMARY DOCUMENT 0001735276-26-000013 Jan 14, 2026 Jan 11, 2026
4 PRIMARY DOCUMENT 0001735276-26-000012 Jan 14, 2026 Jan 11, 2026
4 PRIMARY DOCUMENT 0001735276-26-000011 Jan 14, 2026 Jan 11, 2026
144 0001969223-26-000038 Jan 13, 2026
8-K 8-K 0001628280-26-001755 Jan 12, 2026 Jan 11, 2026
4 PRIMARY DOCUMENT 0001735276-26-000005 Jan 7, 2026 Jan 5, 2026
3 PRIMARY DOCUMENT 0001735276-26-000004 Jan 7, 2026 Jan 5, 2026
8-K 8-K 0001193125-25-315047 Dec 11, 2025 Dec 10, 2025
8-K 8-K 0001628280-25-055084 Dec 3, 2025 Dec 2, 2025
4 PRIMARY DOCUMENT 0001735276-25-000125 Dec 1, 2025 Nov 26, 2025
4 PRIMARY DOCUMENT 0001735276-25-000123 Nov 19, 2025 Nov 17, 2025
144 0001969223-25-000959 Nov 17, 2025
4 PRIMARY DOCUMENT 0001735276-25-000120 Nov 14, 2025 Nov 12, 2025
144 0001969223-25-000940 Nov 12, 2025
SCHEDULE 13G/A 0000315066-25-002664 Nov 5, 2025
10-Q 10-Q 0001628280-25-047345 Oct 30, 2025 Sep 30, 2025